LIFE SCIENCE  | 
PHYSICAL SCIENCE  | 
RESEARCH TOOLS  | 
SOFTWARE AND COPYRIGHT
TECHNOLOGY COMMERCIALIZATION HOME  | 
SEARCH
Search Results - drug+delivery
14
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Fc-folate conjugate for the treatment of triple negative breast cancer
Approximately 13% of women in the United States will develop breast cancer according to the American Cancer Society. That makes breast cancer the second leading cause of cancer death in women right behind lung cancer. Triple negative breast cancer (TNBC) represents about 10 – 20% of all breast cancers. Triple negative refers to cancer cells...
Published: 12/7/2022
|
Inventor(s):
Cecilia Speyer
Keywords(s):
Anti-cancer
,
Breast Cancer
,
Cancer
,
Cancer Therapies
Category(s):
Antibodies
,
Assays
,
Biology
,
Biomedical
,
Chemical Processing/Synthesis
,
Diseases
,
Drug Delivery
,
Life Science
,
Oncology
,
Protein/peptides
,
Receptors/targets
,
Small molecule
,
Therapeutics
Using nanotechnology to target aggressive cancers with a novel small molecule inhibitor of the DNA damage tolerance pathway
Background: Nanotechnology is emerging as a promising tool to target cancer cells. Gold nanoparticles (GNPs) are preferentially taken up by cancer cells when injected into the blood stream and their safety has been demonstrated in human clinical trials. WSU researchers have designed a unique nanoparticle conjugate that combines a GNP with a small molecule...
Published: 8/29/2018
|
Inventor(s):
Malathy Shekhar
,
Guangzhao Mao
,
Yanhua Zhang
Keywords(s):
Category(s):
Life Science
,
Oncology
,
Small molecule
,
Receptors/targets
,
Nano-based
,
Drug Delivery
,
Therapeutics
,
Diseases
An in vivo QQ-systemic protein delivery technology and applications
BackgroundThis invention contains a new composition of our researchers’ previously patented QQ-protein delivery technology and the in vivo applications of this protein delivery technology via systemic administered proteins for cancer diagnosis and therapy. Many proteins and peptides are used as highly specific and effective therapeutic agents....
Published: 11/9/2021
|
Inventor(s):
Jianjun Wang
,
Qianqian Li
,
Quan Jiang
,
Feng Jiang
,
Michael Chopp
Keywords(s):
Cancer Therapies
,
Drug Delivery
Category(s):
Diagnostics
,
Drug Delivery
,
Life Science
,
Oncology
,
Research tools
,
Therapeutics
A protein-induced In situ cell-conversion technology and applications
BackgroundCell reprogramming and trans-differentiation are techniques that convert somatic cells of individuals into either stem cells, including embryonic and adult stem cells (reprogramming) or the other type of somatic cells (trans-differentiation). These techniques are usually performed in the cell culture settings using viral gene delivery and...
Published: 11/9/2021
|
Inventor(s):
Jianjun Wang
,
Qianqian Li
,
Feng Jiang
,
Michael Chopp
,
Guojun Wu
Keywords(s):
Cancer Therapies
,
Drug Delivery
Category(s):
Drug Delivery
,
Life Science
,
Research tools
,
Oncology
Generation of gp78 null mice
Generation of gp78 null mice WSU Tech#: 15-1291 Technology: Generation of the first preclinical experimental model system for gp78-/- C57BL/6 mice, which spontaneously develops age-related nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC), linking endoplasmic reticulum-associated degradation (ERAD) to hepatosteatosis, cirrhosis,...
Published: 11/22/2021
|
Inventor(s):
Avraham Raz
,
Andrei Golovko
Keywords(s):
Category(s):
Animal models
,
Biology
,
Biomedical
,
Biotechnology
,
Drug Delivery
,
Drug Discovery
,
Drug Screening
,
Genomics/Genetics
,
Life Science
,
Oncology
,
Research tools
Targeted
Drug Delivery
for Spinal Cord Injury
Technology Summary: WSU researchers have developed a new nanoparticle-drug conjugate for treating cervical spinal cord injury (SCI) that can restore respiratory function to the paralyzed hemi diaphragm. Using the nano-conjugate enables targeted delivery of the drug directly to the respiratory centers resulting in dramatically lower effective dosages...
Published: 11/11/2021
|
Inventor(s):
Harry Goshgarian
,
Guangzhao Mao
,
Yi Zou
,
Sunxi Wang
Keywords(s):
Central Nervous System
,
Drug Delivery
,
Neuroscience
,
Therapeutics
Category(s):
Therapeutics
,
Life Science
,
Drug Delivery
,
Medical
,
Chemical Processing/Systhesis
,
Nanomaterials
,
Neurological disorders
,
Receptors/targets
Co-polymer Stabilizers for Pressured Metered Dose Inhalers (pMDIs)
A series of novel co polymer surfactants with the general structure LAmEOnLAm were developed along with a Colloidal Probe Microscopy (CPM) method to optimize the surfactant composition using adhesion forces to improve stabilization of drug dispersions. This expands the range of biomolecules and micronized drug particles that can be formulated with pMDIs....
Published: 11/11/2021
|
Inventor(s):
Sandro Da Rocha
,
Libo Wu
Keywords(s):
Assay
,
Asthma
,
Compound
,
Device
,
Drug Delivery
,
Formulation
,
Instrumentation
,
Method
,
Pharmaceuticals
,
Process
,
Therapeutics
Category(s):
Chemicals
,
Drug Delivery
,
Pharmaceuticals
,
Instrumentation
,
Materials
Ruthenium-based caging of nitrile-containing enzyme inhibitors
Technology Summary: Novel synthesis methods for caging nitrile-containing bioactive molecules to a non-toxic ruthenium metal complex have been developed which enable light activated release of a cathespin K inhibitor. Numerous potent and selective cathepsin inhibitors are being developed as drug candidates. Cysteine cathepsins are involved in the pathophysiology...
Published: 10/27/2023
|
Inventor(s):
Jeremy Kodanko
,
Claudia Turro
Keywords(s):
Cancer
,
Pharmaceuticals
Category(s):
Chemicals
,
Drug Delivery
,
Life Science
,
Physical Sciences
,
Other
Nanoparticle Method to Stabilize Suspension-Based pMDI HFA Formulations
Novel nanoparticle-based drug compositions and methods that improve and expand therapeutic
drug delivery
to the lungs through pressurized meter-dose inhalers (pMDIs). A large variety of approaches have been developed at WSU aimed at improving the aerosol characteristics and expanding the range of target species deliverable. These improved formulations...
Published: 11/11/2021
|
Inventor(s):
Sandro Da Rocha
,
Libo Wu
Keywords(s):
Asthma
,
Drug Delivery
,
Formulation
,
Nanomaterials
,
Pharmaceuticals
Category(s):
Drug Delivery
,
Life Science
,
Nano-based
,
Therapeutics
Dual action nanocarrier combining CXCR4 antagonist and polyplex gene delivery for treatment of metastatic cancer and other diseases
Novel bio-reducible polymer compositions which combine the ability to act as a CXCR4 antagonist and simultaneously provide enhanced gene delivery through the formation of inert nanocarrier polyplexes have been developed. As would be expected for biodegradable polymers, the cytotoxicity of these nanocarrier compositions are very low with measured IC50...
Published: 11/11/2021
|
Inventor(s):
David Oupicky
,
Jing Li
Keywords(s):
Cancer
,
Cancer Therapies
,
Compound
,
Drug Delivery
,
Drug Target
,
Formulation
,
Imaging
,
Nanomaterials
,
Pharmaceuticals
,
Therapeutics
Category(s):
Drug Delivery
,
Gene Therapy
,
Therapeutics
,
Life Science
,
Oncology
,
Nano-based
,
Metabolic disorders
,
Biologicals
1
2